BioNexus Gene Lab Corp (NASDAQ:BGLC) does about 368.21K shares in volume on a normal day but saw 25778143 shares change hands in the recent trading day. The company now has a market cap of 6.29M USD. Its current market price is $0.35, marking an increase of 51.32% compared to the previous close of $0.23. The 52 week high reached by this stock is $3.39 whilst the lowest price level in 52 weeks is $0.23.
BioNexus Gene Lab Corp (BGLC) has a 20-day trading average at $0.3097 and the current price is -89.68% off the 52-week high compared with 51.32% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.3640 and its 200-day simple moving average is $0.5088. If we look at the stock’s price movements over the week, volatility stands at 32.77%, which decreases to 13.50% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 56.97 to suggest the stock is neutral.
The current price level is 13.02%, -3.84%, and -31.21% away from its SMA20, SMA50, and SMA200 respectively, with the BGLC price moving above the 50-day SMA on current market day. BioNexus Gene Lab Corp (BGLC) stock is up 20.19% over the week and -2.78% over the past month. Its price is -33.96% year-to-date and -63.16% over the past year.
Outstanding shares total 17.97M with insiders holding 43.72% of the shares and institutional holders owning 0.88% of the company’s common stock. The company has a return on investment of -9.84% and return on equity of -9.87%. The beta has a value of 1.70. Price to book ratio is 0.67 and price to sales ratio is 0.68.
